Resultados negativos asociados a medicamentos (MMS) en pacientes del servicio de medicina interna 7C en el Hospital Nacional Edgardo Rebagliati Martins en los meses de febrero-marzo 2012”

Descripción del Articulo

The pharmaceutical care to hospitalized patients is a useful tool to improve the effectiveness of treatment, prevent problems and avoid diseases, thus unnecessary admissions that diminish the quality of life of patients and generate extra costs for the health system. It is important to rationalize h...

Descripción completa

Detalles Bibliográficos
Autor: Cerna García, Julio César
Formato: tesis de grado
Fecha de Publicación:2013
Institución:Universidad Nacional de Trujillo
Repositorio:UNITRU-Tesis
Lenguaje:español
OAI Identifier:oai:dspace.unitru.edu.pe:20.500.14414/3873
Enlace del recurso:https://hdl.handle.net/20.500.14414/3873
Nivel de acceso:acceso abierto
Materia:Rnm, Seguimiento farmacoterapéutico, Interacción, Prm
Descripción
Sumario:The pharmaceutical care to hospitalized patients is a useful tool to improve the effectiveness of treatment, prevent problems and avoid diseases, thus unnecessary admissions that diminish the quality of life of patients and generate extra costs for the health system. It is important to rationalize health resources to ensure access to the service to patients who really need it. But drug treatment continues to be a problem in hospitalized patients, due to the large amount of drugs used for certain patients, many of whom are of narrow therapeutic. Because of these problems, the present study was conducted to identify those associated with Negative Results Medication patients 7C Internal Medicine at the Hospital National Edgardo Rebagliati Martins during the period of February-March, 2012, by the method Dàder. Accordingly it was determined that the main reason for admission to hospital was for high blood pressure, making 30% of the total. Pharmacotherapeutic monitoring results concerning potential interactions potential interactions were 2.6 per patient, which results in the type whose principal RNM safety, were a total of 51%. Finally it is concluded that the cardiovascular drug group with a higher rate of RNM, making a total of 42 % compared with the other groups.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).